Providers should actively listen and address these issues promptly to ensure the best possible outcomes
Semaglutide suppresses appetite by mimicking the GLP-1 hormone, which activates receptors in the brain
Hims & Hers Semaglutide Weight Loss Program: How Affordable is It, Really
In a statement, Wegovy's maker Novo Nordisk said it was "encouraged" by the new guidance from CMS but said it hopes to see Part D coverage expanded for "obesity medicines when used for chronic weight management." The drug maker is among those pushing for Congress to expand coverage of treatments for obesity
When clinically appropriate, our Northeast Indianapolis providers may prescribe GLP-1 medications including semaglutide and tirzepatide as part of a physician-supervised weight loss program
Week 12+: Continued weight loss, potential dose adjustments, focus on long-term maintenance